EXP vs PFE · P/E 16, rev $2.26B vs P/E 20, rev $62.58B
Eagle Materials Inc (EXP) versus Pfizer Inc (PFE) — a side-by-side from cached financials, not a winner call.
Eagle Materials Inc (EXP) is a building materials company listed on NYSE.
Pfizer Inc (PFE) is a drug manufacturers - general company listed on NYSE. It is led by Albert Bourla.
Latest reported EXP revenue for 2025-03-31 was $2.26B. Net income was $463.4M. Revenue was up 0.1% from 2024-03-31 to 2025-03-31. EXP currently screens at market cap $6.59B and trailing P/E 16.2.
Latest reported PFE revenue for 2025-12-31 was $62.58B. Net income was $7.77B. Revenue was down 1.6% from 2024-12-31 to 2025-12-31. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
EXP currently screens at market cap $6.59B and trailing P/E 16.2. PFE currently screens at market cap $147.73B and trailing P/E 19.8.
Not investment advice. Open the EXP and PFE stock pages for the full models.
Not investment advice.